Continuing Education Credit for this activity is no longer available.
This course can be taken for informational purposes or for Continuing Education (CE) credit.
Continuing Education Credits (CE) released: 11/01/2020; Valid for credit through: 11/01/2021
The target audience for this course consists of a national audience of healthcare providers, including physicians, pharmacists, and nurses.
This online web course will educate a national audience of healthcare providers (physicians, pharmacists, nurses, and others) about the reduction of hypoglycemic events in Type 2 diabetes.
No commercial support was received for this educational activity.
No in-kind commercial support was received for this educational activity.
The following table of disclosure information is provided to learners and contains the relevant financial relationships of each individual in a position to control the content of the course. All of these relationships were treated as a conflict of interest and have been resolved. (C7 SCS 6.1--6.2, 6.5).
|First Name||Last Name||Disclosure|
|Blia||Xiong||Nothing to disclose|
|Sophia||Ni||Nothing to disclose|
|Victoria||Wilson||Nothing to disclose|
|Mary||Ghods||Nothing to disclose|
|Elaine||Frost||Nothing to disclose|
To access the course, users will need a computer with an Internet connection, and:
An HTML5 capable browser is required for video playback. Occasionally, other additional software may be required such as Microsoft PowerPoint or Adobe Acrobat Reader. Viewing on a desktop, laptop, or tablet is recommended.
This is a responsive course. Parts of the course may display differently across various devices and screen resolutions. Scrolling may be required in some instances.
Users are required to view the entire course before getting access to the post-test. To receive your certificate for CE credit or certificate of completion, you must complete the post-test and receive a score of 70 percent or better and complete an evaluation form.
For questions about content or about technical issues, you may contact FDA:
(855) 543-3784, or